https://www.newscientist.com/article/2144520-psychedelic-medicine-the-potential-the-people-the-politics/
Psychedelic treatments:
There is a growing body of evidence that some psychedelic drugs can be used to treat a variety of conditions. Carhart-Harris performed the UK’s first clinical trial of psilocybin – the active ingredient in magic mushrooms – for treatment-resistant depression. It was a small trial with no control group, but the results gave cause for optimism, with 5 of the 12 participants no longer clinically depressed three months after the treatment.
In other psilocybin research, one dose was found to help people with life-threatening cancer face death. Ayahuasca, a hallucinogenic concoction drunk for centuries as part of religious rituals in South America, has also been found to improve hard-to-treat depression. It contains the psychedelic compound dimethyltryptamine (DMT).
While research into psychedelics is still thin on the ground, a meta-analysis of six studies carried out between 1966 and 1970 concluded that LSD was as effective as the standard treatment for alcoholism. And Ibogaine – derived from the iboga plant – has been used to treat heroin addiction. MDMA, or ecstasy, was found to help people who have experienced trauma.
What IS New Scientist Magazine? https://www.newscientist.com/about/
 |
| Ask Your Doctor: Are Magic Mushrooms Right For Me? |
.jpg)
.jpg)
